The Recall Desk
ModerateFDA (Drugs)·D-0621-2018·Announced 2018-04-18

Elroselabs Recalls Conzerol Topical Cream Due to Manufacturing Deviations

Elroselabs Inc. is voluntarily recalling Conzerol topical cream nationwide due to cGMP deviations. The recall was initiated in March 2018 and terminated in December 2020.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source cites cGMP deviations without reporting specific injuries or illnesses, fitting the Moderate severity criteria for voluntary precautionary or minor labeling/process errors.

Plain-English summary

Elroselabs Inc. has voluntarily recalled Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g). The product is identified by NDC 70223-001-06. The recall was initiated on March 28, 2018, and is classified as Class II by the FDA.

The reason for the recall is cited as cGMP (Current Good Manufacturing Practice) deviations. The distribution pattern is listed as nationwide, and the code information indicates all product within expiry is affected. The quantity of product recalled is listed as unknown.

The recall status is currently Terminated, with a termination date of December 15, 2020. The initial firm notification method was a letter. Consumers should check their medication for this specific NDC and contact their healthcare provider or pharmacist for guidance if they have questions about the product.

The recalled product

Product
Conzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 32771 USA --- NDC 70223-001-06
Manufacturer
Elroselabs Inc.
Category
Drug — Topical Cream
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All product within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 3 recalled by Elroselabs Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →

Related recalls

Same manufacturer · Elroselabs Inc.

See all →

Same hazard · cGMP deviations

See all →